Holding in Company

8th February 2018 - 5:03 pm

ImmuPharma PLC (LSE: IMM), the specialist drug discovery and development company, announces that on 8 February 2018 it received notification that Alto Invest no longer holds a notifiable interest in the Company.

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014.

Share this article

Leave a comment